Sudoscan to Exhibit at JNLF 2026 in Marseille
Sudoscan is pleased to announce its participation in the Journées de Neurologie de Langue Française (JNLF) 2026, taking place from April 14 to 17, 2026 at Parc Chanot, Rond Point du Prado, 13008 Marseille, France.
As one of the key events in the francophone neurology landscape, JNLF brings together a wide range of healthcare professionals involved in neurological care. The congress will be held on-site in Marseille, with selected sessions broadcast live online and available in replay for several months after the event, while hands-on workshops remain exclusively accessible in person.
Sudoscan will be present at stand F5 to showcase its innovative, non-invasive technology for the assessment of small fiber and autonomic neuropathies.
About the JNLF Congress 2026
For over 30 years, JNLF has been a major annual meeting dedicated to the advancement of neurology across France and French-speaking countries. Its mission is to promote knowledge, support clinical practice, and foster collaboration between the many societies and professionals involved in the study of the nervous system.
The congress gathers a broad audience including neurologists, researchers, healthcare professionals, and industry partners, offering a unique opportunity to exchange on both scientific and clinical developments.
The 2026 edition in Marseille will once again provide a rich and dynamic scientific programme, featuring:
• Educational sessions and expert-led conferences
• Contributions from numerous neurological societies
• Poster presentations highlighting current research
• Thematic sessions covering a wide range of neurological conditions and practices
The event will also include dedicated highlights such as teaching sessions (JESN), scientific awards, and interdisciplinary workshops, reflecting the diversity of modern neurological practice.
If you want to learn more about the 2026 JNLF’s schedule, click here.
Sudoscan: A Practical Tool for Neuropathy Assessment
Sudoscan is a CE-certified and FDA-cleared Class IIa medical device, designed to provide a rapid and non-invasive evaluation of sudomotor function through the measurement of Electrochemical Skin Conductance (ESC).
By assessing the function of small nerve fibers, Sudoscan supports the early detection of autonomic and peripheral neuropathies, which are often difficult to identify at an early stage.
• Fast: results in under 3 minutes, with no patient preparation
• Non-invasive: painless and easy to perform
• Clinically validated: supported by numerous peer-reviewed studies
This makes Sudoscan a valuable tool in both clinical practice and research settings, particularly in the context of neurological and metabolic disorders.
For more studies on the efficacy of Sudoscan’s technology in neurological disorders, visit our publications page.
Meet Sudoscan at JNLF 2026
We invite neurologists, clinicians, researchers, and healthcare professionals to visit us at stand F5 during JNLF 2026.
Join us to:
• Discover how Sudoscan enables early identification of small fiber and autonomic dysfunction
• Experience live demonstrations of the device
• Discuss with our team how Sudoscan can be integrated into clinical workflows and research protocols
JNLF 2026 is a key opportunity to connect with the francophone neurology community and explore innovative solutions in neurological care.
For full program details, registration, and more information, please visit the official JNLF 2026 website.
We look forward to welcoming you in Marseille!
